Google+ Badge

Friday, July 24, 2015

Cancer Research:New method to halt the advance of liver cancer found ♦ Cancer Driver Gene' reduces metastasis in prostate cancer ♦ Experimental therapy to treat colon cancer,

Cancer Driver Gene' reduces metastasis in prostate cancer A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression.
Breakthrough experimental therapy to treat colon cancer, chronic inflammatory bowel Disease A groundbreaking experimental therapy has been discovered that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.
New method to halt the advance of liver cancer found Drugs targeting the lymphotoxin-beta receptor may improve liver cancer treatment, a new study suggests. The findings could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide.
Two classes of inexpensive generic drugs can reduce breast cancer deaths Two different classes of drugs, aromatase inhibitors and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer, two recent studies indicate. Moreover, the researchers suggest that the two types of drug can be used together, increasing the benefits while also decreasing some side-effects.

Improved outcomes associated with stem cell transplantation for children with serious chronic leukemia Researchers have shown greatly improved outcomes in using stem cell transplantation to treat patients with a serious but very rare form of chronic blood cancer called juvenile myelomonocytic leukemia

No comments:

Post a Comment